2026-10-28 11:01:38 UTC#528239newconfirmednews
IRON stock news
IRON stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire20 wire items
2026-10-28 07:35:29 UTC#526754newconfirmednews
Ironveld PLC reports two-month working capital runway and temporary suspension of supply contract deliveries
2026-10-22 21:13:00 UTC#502885duplicateconfirmednews
Disc Medicine closes $450 million public offering of 6 million shares at $75 per share
tradingviewimportance 0.30trust 0.80Disc Medicine, Inc. 0Jefferies Financial Group Inc. 0Leerink Partners LLC 0+2 entities
2026-10-21 19:37:31 UTC#495284updatereportednews
Majority of Disc Medicine 6 million share offering allocated to 10 investors, report says
2026-10-21 00:59:00 UTC#490042duplicateconfirmednews
Disc Medicine prices upsized public offering of 6 million shares at $75 per share
2026-10-21 00:59:00 UTC#490041updateconfirmedpress release
Disc Medicine grants underwriters 30-day option to purchase up to 900,000 additional shares
2026-10-21 00:59:00 UTC#490040duplicateconfirmednews
Disc Medicine prices upsized $450 million public offering at $75 per share
2026-10-21 00:59:00 UTC#490039duplicateconfirmedpress release
Disc Medicine prices upsized $450 million public offering of 6 million shares at $75 per share
2026-10-21 00:53:30 UTC#490007updateconfirmedpress release
Disc Medicine prices upsized $450 million public offering of 6 million shares at $75 per share
2026-10-21 00:52:00 UTC#490013duplicateconfirmednews
Disc Medicine prices upsized $450M public offering of 6 million shares at $75 per share
2026-10-21 00:52:00 UTC#490012duplicateconfirmedpress release
Disc Medicine prices upsized $450 million public offering of 6 million shares at $75 per share
2026-10-20 18:19:00 UTC#488270newconfirmednews
Morgan Stanley maintains Disc Medicine (IRON) at Overweight, raises price target to $92 from $90
2026-10-20 12:34:40 UTC#486425newconfirmednews
Wedbush maintains Outperform rating on Disc Medicine, sets $110 price target
tradingviewimportance 0.40trust 0.70Wedbush Securities Inc. +0.30Disc Medicine, Inc. +0.30Merck KGaA 0+1 entities
2026-10-19 21:55:38 UTC#483398duplicateconfirmedpress release
Disc Medicine announces proposed $350 million public offering of common stock and pre-funded warrants
2026-10-19 20:15:36 UTC#482841newconfirmednews
Disc Medicine launches $350 million public offering of common stock and pre-funded warrants
2026-10-19 18:01:00 UTC#482261newconfirmednews
BMO Capital raises Disc Medicine (IRON) price target to $120 from $100
2026-10-19 16:05:52 UTC#481733duplicateconfirmednews
Disc Medicine shares surge 35% on positive Phase 3 bitopertin trial, plans FDA resubmission by year-end
reutersimportance 0.40trust 0.90Disc Medicine, Inc. +0.80bitopertin +0.80Food and Drug Administration +0.40+1 entities
2026-10-19 15:28:00 UTC#481477duplicateconfirmednews
Disc Medicine shares surge 35% as bitopertin Phase 3 trial meets primary goals, plans FDA resubmission
dow_jonesimportance 0.40trust 0.80Disc Medicine, Inc. +0.80bitopertin +0.80Food and Drug Administration +0.40
2026-10-19 15:14:00 UTC#481440duplicateconfirmednews
Disc Medicine shares rise 39% following positive Phase 3 trial results for bitopertin in EPP treatment
2026-10-19 14:34:41 UTC#481177newconfirmednews
Cantor Fitzgerald maintains Overweight rating on Disc Medicine, raises price target to $170
tradingviewimportance 0.40trust 0.60Cantor Fitzgerald, L.P. +0.30Disc Medicine, Inc. +0.50bitopertin +0.50+2 entities